Mahesh B. Chandrasekharan

Dr. Mahesh B. Chandrasekharan is an esteemed Assistant Professor in the Department of Radiation Oncology at the School of Medicine, University of Utah. With a robust academic background, he earned his PhD in Biology from Texas A&M University, followed by post-doctoral research at Vanderbilt University Medical Center, where he honed his expertise in molecular biology and genetics. His academic journey has been marked by a commitment to understanding the intricate mechanisms of histone modifications and their implications in cancer biology. Dr. Chandrasekharan's research is primarily centered on histone modifications, transcription, and genome stability. His work delves into the regulation and functions of histone modifications, particularly in the context of cancer development. By employing budding yeast and mammalian cell culture models, his lab conducts both fundamental and cancer-focused studies, aiming to uncover novel insights into epigenetic regulation. His dedication to advancing the field of epigenetics has been recognized through numerous prestigious scholarships and awards, underscoring his significant contributions to the scientific community. Dr. Chandrasekharan's research not only enhances the understanding of epigenetic mechanisms but also explores their potential therapeutic applications in cancer treatment, reflecting his commitment to translating basic science into clinical advancements. In addition to his research endeavors, Dr. Chandrasekharan is passionate about mentoring the next generation of scientists. He actively engages in teaching and guiding students and postdoctoral fellows, fostering an environment of intellectual curiosity and innovation. His mentorship is characterized by a focus on critical thinking and a deep appreciation for the complexities of biological systems. Dr. Chandrasekharan's work continues to push the boundaries of knowledge in the field of epigenetics, with the ultimate goal of contributing to the development of novel therapeutic strategies for cancer. His contributions to the field are not only advancing scientific understanding but also paving the way for new approaches in cancer therapy.